Logo

American Heart Association

  1
  0


Final ID: TP256

Mediation of Successful Reperfusion Effect on Independent Ambulation Through Infarct Growth Reduction in Patients with Large Strokes: A Secondary Analysis of SELECT2 Trial

Abstract Body: Introduction: Reduction in infarct growth is shown to mediate reperfusion effect in patients with small strokes. However, exploration of reperfusion benefit and its mediation through infarct growth among patients with large strokes is limited.

Methods: In a secondary analysis of SELECT2 study, we employed a mediation analysis framework to quantify infarct growth mediation effect on successful reperfusion (mTICI≥2b) association with independent ambulation (mRS 0-3 at 90-day follow-up) using Causal Mediation approach.

Results: Of 180 patients who received EVT, 144 (80%) patients achieved successful reperfusion. Baseline clinical and imaging characteristics were largely similar between those achieving successful vs unsuccessful reperfusion. Median (IQR) infarct growth was 60 (20-128) ml among those with successful reperfusion and 99.5 (85-151.5) ml among those with unsuccessful reperfusion. Successful reperfusion was associated with reductions in infarct growth (adj β, −35.3; 95%CI, −64.6 to −6.0; p=0.018). Controlled direct effect – odds of independent ambulation with successful reperfusion, accounting for change in infarct growth was 2.63 (95%CI:0.93-9.24), whereas natural indirect effect – odds of independent ambulation with average reduction in infarct growth due to successful reperfusion was 1.49 (95% CI:1.09 to 2.47), resulting in total effect (controlled direct effect + natural indirect effect –odds of independent ambulation with cumulative effect of successful reperfusion and reduction in infarct growth associated with successful reperfusion) of 3.92 (95% CI:1.31 to 13.39). Reduction in Infarct growth associated with successful reperfusion explained 29% of cumulative effect of successful reperfusion (controlled direct effect of successful reperfusion and indirect effect - reduction in infarct growth due to successful reperfusion).

Conclusions: In this mediation analysis from SELECT2 trial, only a proportion (~29%) of successful reperfusion effect on functional outcome was mediated through reduction in infarct growth, suggesting a higher proportion of effect mediated through other possible mechanisms. Additional analyses are required to both confirm our findings, detect additional mediators to explain successful reperfusion residual effect and identify novel therapeutic targets to further enhance reperfusion benefits.
  • Sarraj, Amrou  ( University Hospitals Cleveland Med , Cleveland , Ohio , United States )
  • Grotta, James  ( UT Houston McGovern Medical School , Houston , Texas , United States )
  • Ribo, Marc  ( HOSPITAL VALL D HEBRON , Barcelona , Spain )
  • Sitton, Clark  ( UT Houston McGovern Medical School , Houston , Texas , United States )
  • Hill, Michael  ( UNIVERSITY CALGARY , Calgary , Alberta , Canada )
  • Campbell, Bruce  ( Royal Melbourne Hospital , Parkville , Victoria , Australia )
  • Pujara, Deep  ( University Hospitals Cleveland Med , Cleveland , Ohio , United States )
  • Churilov, Leonid  ( Royal Melbourne Hospital , Parkville , Victoria , Australia )
  • Johns, Hannah Tabitha  ( Royal Melbourne Hospital , Parkville , Victoria , Australia )
  • Hassan, Ameer  ( UTRGV - VALLEY BAPTIST MEDICAL CENT , Harlingen , Texas , United States )
  • Abraham, Michael  ( UNIVERSITY OF KANSAS HOSPITAL , Kansas City , Missouri , United States )
  • Hussain, Shazam  ( CLEVELAND CLINIC , Cleveland , Ohio , United States )
  • Chen, Michael  ( Rush University Medical Center , Chicago , Illinois , United States )
  • Ortega-gutierrez, Santiago  ( UNIVERSITY OF IOWA HOSPITALS , Iowa City , Iowa , United States )
  • Author Disclosures:
    Amrou Sarraj: DO have relevant financial relationships ; Research Funding (PI or named investigator):Stryker Neurovascular:Active (exists now) | James Grotta: DO have relevant financial relationships ; Consultant:Frazer Ltd:Active (exists now) ; Advisor:Prolong Pharma:Active (exists now) ; Advisor:Acticor:Active (exists now) ; Advisor:Diamedica:Active (exists now) | Marc Ribo: DO NOT have relevant financial relationships | clark sitton: DO NOT have relevant financial relationships | Michael Hill: DO have relevant financial relationships ; Consultant:Brainsgate Inc:Past (completed) ; Individual Stocks/Stock Options:Circle Inc:Active (exists now) ; Individual Stocks/Stock Options:Basking Bioscience:Active (exists now) ; Research Funding (PI or named investigator):Boehringer-Ingelheim:Active (exists now) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) ; Consultant:Diamedica Inc:Active (exists now) | Bruce Campbell: DO NOT have relevant financial relationships | Deep Pujara: DO NOT have relevant financial relationships | leonid churilov: DO NOT have relevant financial relationships | Hannah Tabitha Johns: DO NOT have relevant financial relationships | Ameer Hassan: DO have relevant financial relationships ; Consultant:Medtronic, Microvention, Stryker, Penumbra, Cerenovus, Genentech, GE Healthcare, Scientia, Balt, Viz.ai , Insera therapeutics, Proximie, NeuroVasc, NovaSignal, Vesalio, Rapid Medical, Imperative Care, Galaxy Therapeutics, Route 92, Perfuze, CorTech, Shockwave and Xcath:Active (exists now) | Michael Abraham: DO have relevant financial relationships ; Consultant:Stryker Neurovascular:Active (exists now) ; Consultant:Q'Apel Medical:Active (exists now) | Shazam Hussain: DO have relevant financial relationships ; Independent Contractor:Cerenovus:Active (exists now) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) ; Independent Contractor:Rapid Medical :Active (exists now) ; Independent Contractor:Stryker :Active (exists now) ; Consultant:Kaneka:Active (exists now) | Michael Chen: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Consultant:Cerenovus:Active (exists now) ; Consultant:Q'Apel:Active (exists now) ; Researcher:Kaneka:Active (exists now) ; Consultant:Penumbra:Active (exists now) ; Consultant:RapidPulse:Active (exists now) | Santiago Ortega-Gutierrez: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Research Funding (PI or named investigator):Methinks:Active (exists now) ; Research Funding (PI or named investigator):Stryker:Active (exists now) ; Research Funding (PI or named investigator):MEdtronic:Active (exists now) ; Researcher:PCORI:Active (exists now) ; Research Funding (PI or named investigator):NIH:Active (exists now) ; Consultant:Stryker:Active (exists now)
Meeting Info:
Session Info:

Neuroendovascular Posters II

Thursday, 02/06/2025 , 07:00PM - 07:30PM

Poster Abstract Session

More abstracts on this topic:
Association of pre-thrombectomy infarct topography and hemorrhagic transformation in patients with acute ischemic stroke: A multicenter Bayesian analysis

Bonkhoff Anna, Simonsen Claus, Patel Aman, Rost Natalia, Regenhardt Robert, Schirmer Markus, Favilla Christopher, Das Alvin, Dmytriw Adam, Gupta Rajiv, Rabinov James, Stapleton Christopher, Leslie-mazwi Thabele

Assessing Effects of Intra-Arterial Verapamil on Cerebral Hemodynamics and Autoregulation Following Aneurysmal Subarachnoid Hemorrhage

Stoehr Kaitlyn, Matouk Charles, Hebert Ryan, Gilmore Emily, Kim Jennifer, Petersen Nils, Jayasundara Sithmi, Vargas David, Thinzar Pwint, Rapuano Amedeo, Maarek Rafael, Beekman Rachel, Magid-bernstein Jessica, Okeefe Lena

More abstracts from these authors:
Effect of Time on EVT Treatment Effect and Clinical Outcomes in Patients with Large Strokes: A Pre-Specified Analysis of SELECT2 Trial

Sarraj Amrou, Sitton Clark, Grotta James, Hill Michael, Ribo Marc, Campbell Bruce, Hassan Ameer, Abraham Michael, Hussain Shazam, Ortega-gutierrez Santiago, Chen Michael, Pujara Deep, Johns Hannah Tabitha, Churilov Leonid

Association of Workflow Metrics with Functional Outcomes in the SELECT2 trial

Jabbour Pascal, Sitton Clark, Churilov Leonid, Hill Michael, Ribo Marc, Campbell Bruce, Gandhi Chirag, Tjoumakaris Stavropoula, Sarraj Amrou, Al-mufti Fawaz, Hassan Ameer, Abraham Michael, Hussain Shazam, Ortega-gutierrez Santiago, Chen Michael, Pujara Deep, Johns Hannah Tabitha

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)